GSK · 10000+ people · Public
Vice President - Oncology Clinical Development, Disease Area Head- Hematology
- Baar Onyx
- Hybrid · 2–3 days in office
- Director · manages people
Leads end-to-end clinical development of hematology oncology assets from first-in-human studies through registrational trials, regulatory approval and initial launch. Chairs governance forums, co-leads matrix asset teams and line-manages clinical development leads, medical directors and clinical scientists. Distinct for its portfolio-level scope across early- and late-phase programs and its cross-functional connector role spanning research, translational medicine and commercial strategy.
AI/ML